Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 3,9013,920 of 20,252 grants

Active RESEARCH CENTERS
University of California and UT Southwestern D-PDTC
NATIONAL CANCER INSTITUTE University of California At Davis United States 2023 – 2028

PROJECT SUMMARY/ABSTRACT The University of California and the University of Texas Southwestern (UCaTS) Diversity Patient-Derived Xenograft (PDX) Development and Trial Center’s is a...

$9.94M
USD
Active RESEARCH CENTERS
Admin Core
NATIONAL CANCER INSTITUTE University of California At Davis United States 2023 – 2028

PROJECT SUMMARY/ABSTRACT The overall goal of this application is to establish and characterize a large collection of minority patient-derived cancer xenografts (PDXs) from two canc...

Active RESEARCH CENTERS
PDX Core
NATIONAL CANCER INSTITUTE University of California At Davis United States 2023 – 2028

PROJECT SUMMARY/ABSTRACT The primary objectives of the Patient Derived Xenograft (PDX) Core will be to establish and characterize PDXs, and to support the research aims of the two...

Active RESEARCH CENTERS
Bioinformatics Core
NATIONAL CANCER INSTITUTE University of California At Davis United States 2023 – 2028

PROJECT SUMMARY The overall objective of the proposed Diversity PDX Development and Testing Center (D-PDTC) is directed at improving cancer precision medicine approaches for gastri...

Active RESEARCH CENTERS
Advancing gastric cancer precision medicine in Latinos through patient-derived modeling
NATIONAL CANCER INSTITUTE University of California At Davis United States 2023 – 2028

PROJECT SUMMARY/ASTRACT Gastric cancer (GC) is a leading cause of cancer incidence, mortality, and survival disparities in Latinos, the largest and youngest U.S. minority and the l...

Active RESEARCH CENTERS
Characterizing treatment responses for common lung cancer (LC) subtypes in Latinos and Asians
NATIONAL CANCER INSTITUTE University of California At Davis United States 2023 – 2028

SPECIFIC AIMS The purpose of UCaTS Project 2 is to target clinically important genomic markers of early resistance to EGFR tyrosine kinase inhibitors (EGFR-TKIs) in EGFR-mutant non...

Active RESEARCH CENTERS
Pilot Projects and Trans-Network Activities
NATIONAL CANCER INSTITUTE University of California At Davis United States 2023 – 2028

PILOT PROJECTS AND TRANS-NETWORK ACTIVITIES CORE University of California and UT Southwestern Diversity Patient-Derived Xenograft (PDX) Development and Trial Center (UCaTS) to Redu...

Active NON-SBIR/STTR RPGS
Cannabis for Palliative Care in Cancer: A Placebo-controlled Randomized Trial of Full Spectrum Hemp-derived CBD/THC
NATIONAL CANCER INSTITUTE University of Colorado United States 2023 – 2028

Project Summary Problems with pain, sleep, and mood are common among individuals diagnosed with cancer (i.e., cancer survivors/patients), and many are turning to cannabis for sympt...

$6.14M
USD
Active TRAINING, INDIVIDUAL
Neoantigen-specific T cells in a novel cutaneous squamous cell carcinoma model
NATIONAL CANCER INSTITUTE University of Arizona United States 2023 – 2026

Abstract: More than one million cases of cutaneous squamous cell carcinoma (cSCC) are diagnosed annually in the US and approximately 4% of patients develop metastases and 2% die of...

$539.7K
USD
Active TRAINING, INDIVIDUAL
Elucidating the distinct roles of T cell-polarized microglia in glioblastoma suppression and progression
NATIONAL CANCER INSTITUTE Salk Institute for Biological Studies United States 2023 – 2027

Project Summary/Abstract Glioblastoma is a grade IV diffuse astrocytoma, the deadliest and most common form of adult brain cancer. Standard of care extends survival by approximatel...

$414.7K
USD
Completed TRAINING, INDIVIDUAL
Mechanism of cell lethality following loss of gene expression.
NATIONAL CANCER INSTITUTE University of Massachusetts Med Sch Worc... United States 2023 – 2025

PROJECT SUMMARY The goal of this project is to determine the mechanism by which cell death results from transcriptional inhibition. The consensus model in the field posits that cel...

$337.6K
USD
Active TRAINING, INDIVIDUAL
Mitochondrial Regulation of Interferon Response in Melanoma
NATIONAL CANCER INSTITUTE Salk Institute for Biological Studies United States 2023 – 2026

PROJECT SUMMARY Interferons (IFNs) are central orchestrators of tumor immunity and can elicit both pro-tumor and anti-tumor responses depending on the cancer cell type, the type of...

$418K
USD
Completed NON-SBIR/STTR RPGS
Delineating Functional Immunity via Image-Guided PET
NATIONAL CANCER INSTITUTE Wayne State University United States 2023 – 2025

Abstract Immunotherapy has made an enormous impact in the treatment of multiple types of cancer, however most patients fail to benefit and methods to monitor response are lacking....

$5.54M
USD
Active NON-SBIR/STTR RPGS
Sulindac sensitizes colorectal cancer to anti-PD-L1 therapy
NATIONAL CANCER INSTITUTE University of Georgia United States 2023 – 2027

Project Summary: The overall survival of colorectal cancer (CRC) patients has improved significantly over the past few decades, but the 5-year survival rate for patients with stage...

$5.33M
USD
Active OTHER RESEARCH-RELATED
Defining pro-metastatic and endothelial-regulatory roles for LIN28B in hepatocellular carcinoma
NATIONAL CANCER INSTITUTE University of Chicago United States 2023 – 2027

PROJECT SUMMARY Hepatocellular carcinoma (HCC) is a lethal solid tumor that is highly dependent on recruitment of new blood vessels and has no common genomic targets. As for most s...

$2.65M
USD
Completed TRAINING, INDIVIDUAL
Mechanisms of REST-mediated immunosuppression in cancer
NATIONAL CANCER INSTITUTE Brigham and Women'S Hospital United States 2023 – 2025

Project Abstract Tumor-intrinsic factors in cancer cells modulate the immune milieu to enable prolonged survival and growth of tumors. In breast cancer (BC), the 2nd leading cause...

$742.8K
USD
Completed TRAINING, INDIVIDUAL
The Role of SKIDA1 in Acute Myeloid Leukemia Initiation and Maintenance
NATIONAL CANCER INSTITUTE Washington University United States 2023 – 2026

ABSTRACT Chromosomal translocations involving the MLL1 gene often drive infant acute myeloid leukemia (AML). MLL fusion proteins (e.g., MLL-ENL, MLL-AF9, MLL-AF10) activate self-re...

$349.3K
USD
Completed TRAINING, INDIVIDUAL
Studying the role of TERRA in telomere protection and length regulation
NATIONAL CANCER INSTITUTE Johns Hopkins University United States 2023 – 2024

PROJECT SUMMARY Telomeres are specialized DNA-protein complex that protect the ends of linear chromosomes. Mammalian telomeres are composed of highly conserved tandem repeat sequen...

$254.3K
USD
Active TRAINING, INDIVIDUAL
Effects of entinostat and neoantigen vaccination on bladder cancer
NATIONAL CANCER INSTITUTE University of North Carolina Chapel Hill United States 2023 – 2026

Project Summary/Abstract Bladder cancer is a prevalent and deadly cancer, with over 80,000 new cases and 17,000 deaths annually in the United States. Advanced bladder cancer has on...

$539.7K
USD
Active NON-SBIR/STTR RPGS
Evaluation of Patient Factors and Sample Pre-Analytics on Predictive Multiplex Immunohistochemical Assays in Immuno-Oncology Patients
NATIONAL CANCER INSTITUTE Beth Israel Deaconess Medical Center United States 2023 – 2027

Project Summary/Abstract Therapies against immunologic checkpoint proteins, such as PD-L1, have revolutionized the treatment of multiple malignancies, such as malignant melanoma, l...

$3.65M
USD